Optimizing Medication Therapy for Bipolar Disorder: A Case Study

QUESTION

Laura is a woman who is 28 years old and has bipolar illness type I. You’ve been giving her lithium ER 300mg PO BID to help her. She says her emotions are more steady, but she is still having trouble with depression symptoms, especially feeling alone and not wanting to do anything. She says she feels like she is in a “dark hole of depression.”

Vital signs: BP: 110/78, P: 88; R: 18; Pulse ox: 98%

Allergies: PCN

Questions:

1) would you add or change his medication, and if so, what medication, dose, and time of administration? Provide current literature (EBP, research article, or text reference) to support your decision.

2) Based on the medication you prescribe, what education would you provide James?

3) How are atypical antipsychotics theorized to be effective in bipolar disorder?

ANSWER

Optimizing Medication Therapy for Bipolar Disorder: A Case Study

Introduction

Bipolar disorder is a chronic mental health condition characterized by alternating periods of mania and depression. Medication therapy plays a crucial role in managing bipolar disorder symptoms and promoting stability. In this case, Laura, a 28-year-old woman with bipolar disorder type I, is experiencing persistent depressive symptoms despite treatment with lithium. This essay will discuss the considerations for adding or changing her medication, provide relevant literature to support the decision, outline patient education, and explore the effectiveness of atypical antipsychotics in bipolar disorder treatment.

Medication Adjustment

Considering Laura’s ongoing depressive symptoms, it may be appropriate to augment her current treatment with an atypical antipsychotic medication. Studies have shown that combining mood stabilizers, such as lithium, with atypical antipsychotics can improve depressive symptoms in bipolar disorder (Vieta et al., 2018). Quetiapine, an atypical antipsychotic, has demonstrated efficacy in treating bipolar depression and is often used as an adjunctive therapy.

Recommended Medication and Dosing
Quetiapine XR (extended-release) 50 mg PO daily, administered at bedtime. The dose can be titrated up to a therapeutic range (e.g., 200-300 mg/day) based on individual response and tolerability (Goodwin et al., 2016).

Literature Reference
Goodwin, G. M., Haddad, P. M., Ferrier, I. N., Aronson, J. K., Barnes, T. R., Cipriani, A., … & Young, A. H. (2016). Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology, 30(6), 495-553.

Patient Education

When prescribing quetiapine, it is important to provide comprehensive education to Laura. Key points to address include:

Medication Purpose: Explain that quetiapine is an atypical antipsychotic that helps stabilize mood and reduce depressive symptoms in bipolar disorder.

Dosage and Administration: Instruct Laura to take the medication as prescribed, emphasizing the importance of consistency and regularity. Taking it at bedtime may help mitigate potential sedating effects.

Potential Side Effects: Discuss common side effects such as drowsiness, dizziness, and weight gain. Inform Laura that these side effects are generally manageable and often diminish over time. Encourage her to report any adverse effects promptly.

Adherence and Monitoring: Emphasize the importance of adhering to the prescribed regimen and attending follow-up appointments to monitor treatment response and adjust the medication as needed.

Effectiveness of Atypical Antipsychotics

Atypical antipsychotics are theorized to be effective in bipolar disorder due to their modulation of various neurotransmitters, including dopamine and serotonin. These medications have demonstrated mood-stabilizing properties and can alleviate depressive symptoms (Vieta et al., 2018). By targeting multiple neurochemical pathways, atypical antipsychotics help restore the balance of brain activity and improve overall mood stability in bipolar disorder.

Conclusion

In the case of Laura, who is experiencing ongoing depressive symptoms despite treatment with lithium, adding quetiapine, an atypical antipsychotic, may be beneficial. Evidence supports the use of atypical antipsychotics as adjunctive therapy in bipolar depression. Providing patient education about the new medication, including dosing, potential side effects, and adherence, is crucial to optimize treatment outcomes. The effectiveness of atypical antipsychotics in bipolar disorder is attributed to their ability to modulate neurotransmitters and restore mood stability. By implementing this individualized treatment approach, we aim to alleviate Laura’s depressive symptoms and enhance her overall well-being.